期刊文献+

白介素-1基因与中国人散发性帕金森病的关系 被引量:2

Relationship Between Interleukin-1 Gene and Chinese Sporadic Parkinson's Disease
原文传递
导出
摘要 目的探讨白介素-1受体拮抗剂基因(IL-1RA)及白介素-1β基因多态性与帕金森病(PD)的关系。方法本实验用PCR-片段长度多态性分析法检测了89例中国散发性帕金森病病人和67例正常对照的IL-1RA基因串联重复序列(VNTR)和IL-1β基因多态性。结果IL-1RAVNTR基因多态性在散发性PD组与正常对照组之间差异无统计学意义(P>0.05),IL-1RAVNTR基因多态性在帕金森病合并痴呆亚型(PDD组)和非痴呆亚型(PDND组)之间差异有统计学意义(P<0.05);IL-1β基因C-511T多态性在散发性PD组与正常对照组之间差异有统计学意义(P<0.05),但IL-1β基因C-511T多态性在PDD组和PDND组之间差异无统计学意义(P>0.05)。结论提示IL-1RA基因多态性可能与我国人散发性帕金森病的发病无关,而与帕金森病并发痴呆发病过程中有关;IL-1β可能是散发性帕金森病的易感基因之一。 Objective To explore the relationship between interleukin-1 receptor antagonist (IL-1RA) and interleukin-1β genetic polymorphism with sporadic Parkinson’s disease (PD).Methods IL-1RA and interleukin-1β genetic polymorphisms in 89 sporadic PD patients and 67 healthy controls were analyzed with the polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) technique.Results No statistically significant difference was found in IL-1RA genetic polymorphism between PD group and control group (P0.05),but there were statistically significant differences in IL-1RA genetic polymorphism between PD with dementia group (PDD) and PD without dementia group (PDND),(P0.05).There were statistically significant differences in interleukin-1β (C-511T) genetic polymorphism between PD and control groups (P0.05),but no statistically significant difference was found in interleukin-1β (C-511T) genetic polymorphism between PDD group and PDND group (P0.05).Conclusions The results suggest that IL-1RA genetic polymorphism may not be related to the pathogenesis of sporadic PD,but may be related to the pathogenesis of PDND.The IL-1β may be one of the susceptible genes for sporadic PD.
作者 蒋萍
出处 《实用预防医学》 CAS 2010年第4期669-671,628,共4页 Practical Preventive Medicine
关键词 帕金森病 痴呆 白介素-1受体拮抗剂 多态性 Parkinson’s disease Dementia Interleukin-1 receptor antagonist Polymorphism
  • 相关文献

参考文献11

  • 1董丽华,胡国华,王玉珊.帕金森病的临床诊断分析[J].中国综合临床,2005,21(12):1081-1082. 被引量:3
  • 2Arai H,Furuya T, Mizuno Y, et al. Inflammation and infection in Parkinson's disease[J]. Histol Histopathol,2006,21(6) ;673- 678.
  • 3Merello M, Nouzeilles MI, Arce GP. Accuracy of acute levodopa chat lenge for ctinical prediction of sustained tong - term levodopa response as a major criterion for idiopathic Parkinson' s disease diagnosis[ J ]. Mov Disord,2002,17 (4) : 795 - 798.
  • 4Smith PF. Inflammation in Parkinson' s disease: an update [ J ]. Curr Opin Investig Drugs, 2008,9 (5) : 478 - 484.
  • 5Giunta B, Fernandez F, Nikolie WV, et al. Inflammaging as a prodrome to Alzheimer's disease[J]. J Neuroinflammation,2008,11(5) :51.
  • 6Mrak RE, Griffin WS. Common inflammatory mechanisms in Lewy body disease and Alzheimer disease [J]. J NeuropatholExp Neurol, 2007,66(8) :683 - 686.
  • 7Griffin WS, Liu L, Li Y, et al. Interleukin- 1 mediates Alzheimer and Lewy body pat hologies [ J ]. J Neuroinflammation, 2006,9 (3) : 5.
  • 8Dinarello CA. The IL 1 family and inflammatory diseases[J]. Clin Exp Rheumatol, 2002,20(5 Suppl,27) ;S1 - 13.
  • 9马朋林,陈德昌,潘家绮,杜斌.白细胞介素-1家族细胞因子基因多态性对全身性感染患者预后的影响[J].中华医学杂志,2002,82(18):1237-1241. 被引量:29
  • 10Williams Gray CH, Foltynie T, Lewis SJ, et al. Cognitive deficits and psychosis in Parkinson' s disease: a review of pathophysiology and therapeutic options[ J ]. CNS Drugs, 2006,20 (6) : 477 - 505.

二级参考文献7

  • 1Gelb DJ,Oliver E,Gilman S.Diagnostic criteria for parkinson disease[J].Arch Neurol,1999,56(1):33-39.
  • 2Crucian GP,Huang L,Barrett AM,et al.Emotional conversations in Parkinson's disease[J].Neurology,2001,56(2):159-165.
  • 3A. Gullo,G. Berlot. Sepsis[J] 1999,Intensive Care Medicine(8):869~871
  • 4A. Nemetz,M. Pilar Nosti-Escanilla,Tamás Molnár,Adorján K?pe,ágota Kovács,János Fehér,Zsolt Tulassay,Ferenc Nagy,M. Asunción García-González,A. S. Pe?a. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease[J] 1999,Immunogenetics(6):527~531
  • 5Sabine Bailly,Francesco S. Giovine,Gordon W. Duff. Polymorphic tandem repeat region in interleukin-1α intron 6[J] 1993,Human Genetics(1):85~86
  • 6郭玉璞.帕金森病的临床表现[J].中国实用内科杂志,1999,19(6):324-325. 被引量:2
  • 7陈生弟.我国帕金森病的研究进展(述评)[J].中国神经免疫学和神经病学杂志,2001,8(2):67-69. 被引量:12

共引文献30

同被引文献13

  • 1Demonty I, Ras RT, van der Knaap HC, et al. Continuous dose - re- sponse relationship of the LDL- cholesterol - lowering effect of phytos- terol intake[J]. J Nutr, 2009,139(2):271 -284.
  • 2Yu Y, Zhou L, Sun M, et al. Xybcoside G reduces amyloid - β in- duced neurotoxicity by inhibiting NF- κB signaling pathway in neuronal cells[J] .J Alzheimers Dis, 2012,30(2) :263 - 275.
  • 3Li M, Sun M, Liu Y, et al. Copper downregulates neprilysin activity through modulation of neprilysin degradation [J ]. J Alzheimers Dis, 2010,19(1) : 161 - 169.
  • 4Sun M, Zhou T, Zhou L, et al. Formononetin protects neurons against hypoxia- induced cytotoxicity through upregulation of ADAM10 and sAβPPα[J]. J Alzheimers Dis, 2012,28(4):795- 808.
  • 5Bolling BW, McKay DL, Blumberg JB. The phytochemical composition and antioxidant actions of tree nuts[J]. Asia Pac J Clin Nutr, 2010,19 (1) :117 - 123.
  • 6Ballal K, Wilson CR, Hammncey R, et al. Obesogenic high fat western diet induces oxidative stress and apoptosis in mt heart[J]. Mol Cell Bio- chem,2010,344(1 - 2) :221 - 230.
  • 7Huang X, Chen H, Miller WC, et al. Lower LDL cholesterol levels are associated with Parkinson' s disease: a case control 8tudy[J ]. Mov Disord, 2007,22 (3) : 377 - 381.
  • 8Wang H, Sun M, Yang H,et al. Hypoxia- inducible factor- 1α med- iates up- regulation of neprilysin by histone deacetylase - 1 under hy- poxia condition in neuroblastoma cells [J ]. J Neurochem, 2014, doi: 10. 1111/jnc. 12795.
  • 9Du G,Lewis MM,Shaffer ML, et al. Serum cholesterol and nigrostri- ata1 R2* values in Parkinson' s disease[J]. PLoS One, 2012,7(4) : e35397.
  • 10孙云闯,秦斌.中文版MoCA和MMSE在诊断遗忘型轻度认知功能障碍中的应用[J].中国神经免疫学和神经病学杂志,2011,18(2):91-93. 被引量:95

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部